Saffron Drug, Supplement and Food Interactions

Saffron is the dried stigma of Crocus sativus. It is used as a spice and, increasingly, as a standardized extract taken for mood, sleep, appetite, eye health and menstrual symptoms. Anyone who takes a medicine or another supplement alongside saffron reasonably wants to know whether the combination is safe.

The honest answer is that saffron has been studied far more for benefits than for interactions. There are very few controlled studies that tested saffron together with a specific drug in order to measure an interaction. Most guidance therefore rests on small clinical trials, laboratory and animal research, and pharmacological reasoning. This page separates what is documented from what is only possible, and it takes a conservative approach where evidence is thin. It is for information only and is not medical advice.

1. Interaction Summary

No saffron interaction with a specific drug has been firmly established in large, well-designed human studies. The cautions that appear in reference works are mostly precautionary and fall into a few themes: effects on blood pressure, effects on mood-related and sedating medicines, possible effects on blood clotting, possible effects on blood sugar, and unknown effects on how the body processes some drugs.

•       Culinary amounts of saffron (a few threads) are very unlikely to cause meaningful interactions.

•       Supplement doses (commonly 20 to 100 mg per day of extract) carry a small but real chance of additive effects with certain medicines.

•       Medicines that deserve the most caution: blood pressure drugs, antidepressants and other serotonergic drugs, sedatives, blood thinners and antiplatelets, and diabetes medicines.

•       Supplements that deserve attention: other sedating, mood-active, blood-pressure-lowering, blood-sugar-lowering or blood-thinning products.

•       Food interactions are poorly studied. Alcohol and caffeine are the most practical considerations.

•       Evidence strength is mostly low. Absence of reported interactions is not proof of safety.

2. How Interactions Are Identified

Understanding how interactions are found helps readers judge how much weight to give any warning.

Pharmacodynamic interactions

These occur when two substances act on the same body system and their effects add together or oppose each other. Examples are two products that both lower blood pressure, or two that both cause drowsiness. They are often predicted from known actions, and for saffron the main predictions rely on its reported effects on mood, sleep, blood pressure and glucose.

Pharmacokinetic interactions

These occur when one substance changes how another is absorbed, broken down or removed. Common routes include liver enzymes (the cytochrome P450 family) and transport proteins such as P-glycoprotein. For saffron, only limited laboratory and animal data exist on these pathways, and results do not clearly translate to people.

Sources of evidence

•       Controlled human trials designed to measure an interaction (essentially absent for saffron).

•       Clinical trials in which saffron was added to standard treatment, with safety recorded as a secondary result.

•       Case reports and pharmacovigilance reports of unexpected effects.

•       Laboratory (in vitro) and animal studies on enzymes, platelets or receptors.

•       Pharmacological reasoning based on the known actions of the plant's compounds, such as crocin, crocetin, picrocrocin and safranal.

Each source has limits. Trial participants are carefully selected and monitored, case reports cannot prove cause, and laboratory results may not hold at realistic doses in the body. A conservative reference therefore labels each interaction by the type of evidence behind it.

3. Drug Classes of Concern

The table summarizes classes of medicine commonly flagged in the literature, the reason for concern and how strong the supporting evidence is. The evidence labels are explained in section 9.

Drug class	Reason for concern	Evidence type	Level of caution
Antihypertensives	Possible additive blood pressure lowering	Small human studies, mechanism	Moderate
Antidepressants (SSRIs, others)	Overlapping mood and serotonin effects	Trials of add-on use, mechanism	Moderate
Sedatives and sleep medicines	Possible additive drowsiness	Trial side effects, mechanism	Moderate
Anticoagulants and antiplatelets	Possible effect on platelets and clotting	Laboratory, theoretical	Moderate
Diabetes medicines	Possible additive glucose lowering	Small trials, mechanism	Moderate
Drugs for bipolar disorder or mania	Mood switching risk	Case-level reports, mechanism	High in bipolar disorder
Drugs with narrow dosing margins	Unknown effects on metabolism	Preclinical only	Precautionary

 

"Moderate" in this table means that talking with a clinician or pharmacist is sensible before regular use. It does not mean that the combination is known to be dangerous.

4. Specific Documented Interactions

The word "documented" must be used carefully with saffron. There are no widely accepted, clinically confirmed saffron-drug interactions of the kind found for substances such as St John's wort. What exists is a set of observations that offer partial guidance.

Antidepressants

Several randomized trials compared saffron with fluoxetine, sertraline, citalopram or imipramine and found similar short-term improvement in mild to moderate depression. A smaller number of trials gave saffron alongside an SSRI, and the combinations were generally tolerated over several weeks. These studies were not designed as interaction studies, they were small and short, and rare events such as serotonin syndrome could not be excluded. The observation is reassuring in a limited way but does not establish that combining saffron with antidepressants is risk-free.

Blood pressure

In healthy volunteers receiving saffron or its constituent crocin at doses well above typical supplement doses, small reductions in blood pressure have been reported. Participants who were already using antihypertensive drugs were not the focus of these studies, so the size of an additive effect is unknown.

Metabolic medicines

Small trials in people with diabetes or metabolic syndrome have tested saffron alongside usual treatment such as metformin, and some report modest improvements in blood sugar measures. These findings suggest that saffron could add to the effect of glucose-lowering drugs, although episodes of low blood sugar have not been prominently reported.

Antipsychotics

A few small trials have studied saffron as an add-on to antipsychotic treatment, and these generally reported no major safety problems. The data are limited and do not support firm conclusions.

In summary, the documented information is mainly that combinations were used in trials without prominent harms. Larger and purpose-designed studies are needed.

5. Theoretical and Mechanistic Interactions

The following concerns arise from laboratory data or pharmacological reasoning. They are possibilities, and in many cases they may never occur at supplement doses.

Bleeding and clotting

Laboratory research suggests that saffron compounds may reduce platelet aggregation. If this happened in people, it could in theory add to the effect of warfarin, direct oral anticoagulants, clopidogrel, aspirin or non-steroidal anti-inflammatory drugs. Clinical trials have not shown increased bleeding, but they were not powered to detect it. Because of this, caution is commonly advised for people on blood thinners and before surgery.

Drug-metabolizing enzymes and transporters

Preclinical studies have examined whether saffron extract, crocin or crocetin influence cytochrome P450 enzymes or P-glycoprotein. Results vary by model and do not give a clear picture for humans. For medicines with a narrow margin between effective and harmful doses, such as lithium, digoxin, warfarin, some anti-seizure drugs and immunosuppressants like tacrolimus or cyclosporine, even a small and unproven effect would matter. This is why a precautionary approach is reasonable, not because an interaction has been shown.

Serotonin and monoamine pathways

Saffron has been proposed to influence serotonin, dopamine and noradrenaline signaling. Theoretically, combining it with monoamine oxidase inhibitors, triptans, tramadol, linezolid or other serotonergic drugs could increase the risk of excess serotonin effects. No cases are firmly attributed to saffron, but the mechanism supports a cautious approach.

Sedation

Drowsiness and dizziness are among the reported side effects. Combining saffron with benzodiazepines, z-drugs, opioids, sedating antihistamines, gabapentinoids or alcohol could, in theory, add to this effect.

Blood sugar

If saffron lowers blood glucose slightly, people using insulin or sulfonylureas could be more prone to low blood sugar. This possibility has not been well tested.

Cancer treatment

Saffron compounds have been studied in cell and animal cancer models, with mixed effects on tumor cells and on the actions of chemotherapy. Human data are lacking. People receiving cancer treatment should discuss any supplement, including saffron, with their oncology team.

6. Supplement-Supplement Interactions

Many people use saffron in combination products or alongside other supplements. No controlled studies of these combinations exist for interaction outcomes, so the points below are precautionary.

•       Serotonergic or mood-active supplements (St John's wort, SAMe, 5-HTP, L-tryptophan): possible overlapping effects. This combination deserves the most caution.

•       Sedating herbs (valerian, kava, passionflower, lemon balm, ashwagandha) and melatonin: possible additive drowsiness.

•       Supplements that may affect bleeding (fish oil, high-dose vitamin E, garlic, ginkgo, ginger, turmeric or curcumin): a theoretical additive effect on clotting.

•       Supplements that may lower blood pressure (garlic, magnesium, coenzyme Q10, hibiscus): possible additive lowering.

•       Supplements that may lower blood sugar (berberine, cinnamon, chromium, bitter melon, alpha-lipoic acid): possible additive effect.

•       Multi-ingredient formulas: the more active ingredients a product contains, the harder it is to know which one causes an effect. Check labels for hidden duplicates.

A practical approach is to add one new supplement at a time, keep a simple list of everything taken, and share it with a pharmacist or doctor.

7. Food Interactions

Specific food-saffron interactions have not been documented in human studies. The following are practical and theoretical considerations.

Culinary use

Saffron eaten in rice, soups, desserts or milk drinks has a long history of use, and no food combination is known to be harmful. The amounts used in cooking are small.

Alcohol

Alcohol may add to drowsiness and dizziness and can affect blood pressure and blood sugar. Combining it with saffron supplements, especially along with sedating medicines, is a sensible thing to limit.

Caffeine

Some people report anxiety or sleep changes with saffron, and caffeine can have the same effect. No formal interaction is established, but sensitive individuals may prefer to reduce caffeine when starting a saffron supplement.

Grapefruit and other enzyme-affecting foods

Grapefruit affects some drug-metabolizing enzymes. There is no evidence that it changes saffron levels, and the question has not been studied.

Meals and absorption

Saffron's pigments are partly converted in the gut, and the effect of food on absorption has not been clearly characterized. Taking a supplement with food may reduce stomach upset, though this is not well tested.

Adulterated saffron

Saffron is frequently adulterated with materials such as turmeric, safflower, marigold petals, dyes or plant fibers. Safflower, for example, has its own effects on platelets. Low-cost or unlabeled products could therefore carry interaction risks that are not caused by saffron itself.

8. Lab-Test Interference If Relevant

No well-documented direct interference of saffron with laboratory assays has been reported. The more relevant issue is that saffron might change the body's actual results, which could be misread if the supplement is not disclosed.

•       Blood pressure: small reductions may be recorded at higher doses.

•       Blood glucose and HbA1c: modest reductions have been seen in some trials, which may affect diabetes monitoring and medicine adjustment.

•       Clotting tests (PT/INR, platelet function): effects are theoretical, but anyone on warfarin should have INR monitored carefully when starting or stopping a new supplement.

•       Liver and kidney markers: small changes were reported in high-dose volunteer studies, though results at standard doses are generally unremarkable.

•       Blood counts: minor shifts within normal ranges have been observed in some studies.

Tell your clinician and the laboratory team about saffron use before tests, particularly before surgery, because they may interpret results differently.

9. Severity and Strength of Evidence

A conservative interaction reference should be clear about how confident each statement is. The framework below is used throughout this page.

Evidence level	Meaning	Examples for saffron
Level 1: Confirmed	Interaction shown in controlled human studies	None established
Level 2: Clinical signals	Observed in human trials or case reports, not designed as interaction studies	Add-on use with antidepressants, glucose and blood pressure changes
Level 3: Mechanistic	Laboratory or animal data suggesting a pathway	Platelet effects, enzyme and transporter effects
Level 4: Theoretical	Predicted from class effects or traditional use	Serotonergic combinations, sedative combinations

 

For severity, think in practical terms. Additive drowsiness or dizziness is usually mild to moderate. A change in blood pressure or blood sugar could be important in people on several medicines. Interactions affecting narrow-margin drugs or bleeding would be more serious if they occurred, which is why caution is higher in those groups even though the evidence is weak.

Overall evidence quality is low. Trials are generally small, short, heterogeneous in extract type and dose, and not designed to find interactions.

10. Who Should Consult a Clinician

Speak with a doctor or pharmacist before using saffron supplements if any of the following apply.

•       You take prescription medicines, especially for blood pressure, depression, anxiety, sleep, diabetes or blood clotting.

•       You take medicines with a narrow safety margin, such as lithium, digoxin, warfarin, anti-seizure drugs or transplant medicines.

•       You have bipolar disorder, a history of mania, or a serious mental health condition.

•       You have low blood pressure, a bleeding disorder, liver disease or kidney disease.

•       You are scheduled for surgery or a dental procedure (many clinicians advise stopping supplements about two weeks before).

•       You are pregnant, breastfeeding or trying to conceive.

•       You are receiving cancer treatment.

•       You use several supplements or multi-ingredient formulas.

•       You are older, as sensitivity to blood pressure and sedative effects is often higher.

Seek urgent care if you develop severe dizziness or fainting, unusual bleeding or bruising, agitation with fever, muscle stiffness or tremor, confusion, a very rapid heartbeat, or swelling and breathing difficulty after combining saffron with other substances.

11. FAQ

Does saffron interact with antidepressants?

Saffron has been used with SSRIs in a few small trials without prominent safety problems, but no one can rule out interactions. Because both can influence mood and serotonin pathways, discuss the combination with your prescriber.

Can I take saffron with blood thinners?

A direct interaction has not been proven, but laboratory studies suggest saffron may affect platelets. People on warfarin, DOACs or antiplatelet drugs should ask their clinician first and have monitoring if advised.

Can saffron lower blood pressure?

At higher doses it has lowered blood pressure slightly in some studies. If you take blood pressure medicine, monitor your readings and ask your doctor.

Is saffron safe with diabetes medicines?

Some studies suggest a modest blood sugar lowering effect. People on insulin or sulfonylureas should watch for low blood sugar and consult their care team.

Can I take saffron with St John's wort or 5-HTP?

This combination is not recommended without professional advice because of overlapping effects on mood and serotonin pathways.

Does saffron interact with alcohol?

Both may cause drowsiness or dizziness. Limiting alcohol while taking saffron supplements is sensible.

Do culinary amounts of saffron interact with medicines?

This is very unlikely. The small quantities used in cooking are far below typical supplement doses.

Does saffron affect lab tests?

No direct assay interference is documented, but saffron may change blood pressure, glucose or clotting-related results. Tell your clinician about any supplement.

Should I stop saffron before surgery?

Many clinicians advise stopping about two weeks before elective surgery because of theoretical bleeding and sedation effects. Follow your surgical team's advice.

How do I check a specific interaction?

Ask a pharmacist, use a professional interaction database, and bring the supplement label to your appointment.

12. References

Verify each citation against the original source and update with current publications before publishing.

1.     Bostan HB, Mehri S, Hosseinzadeh H. Toxicology effects of saffron and its constituents: a review. Iran J Basic Med Sci. 2017;20(2):110-121.

2.     Hausenblas HA, Saha D, Dubyak PJ, Anton SD. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. J Integr Med. 2013;11(6):377-383.

3.     Lopresti AL, Drummond PD. Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Hum Psychopharmacol. 2014;29(6):517-527.

4.     Marx W, Lane M, Rocks T, et al. Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis. Nutr Rev. 2019;77(8):557-571.

5.     Modaghegh MH, Shahabian M, Esmaeili HA, Rajbai O, Hosseinzadeh H. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine. 2008;15(12):1032-1037.

6.     Mohamadpour AH, Ayati Z, Parizadeh MR, Rajbai O, Hosseinzadeh H. Safety evaluation of crocin (a constituent of saffron) tablets in healthy volunteers. Iran J Basic Med Sci. 2013;16(1):39-46.

7.     Schmidt M, Betti G, Hensel A. Saffron in phytotherapy: pharmacology and clinical uses. Wien Med Wochenschr. 2007;157(13-14):315-319.

8.     National Institutes of Health, National Center for Complementary and Integrative Health. Safety and drug interaction resources on botanical supplements.

9.     ISO 3632: Spices - Saffron (Crocus sativus L.) - Specification and test methods.

Disclaimer: This content is for general information only and does not replace professional medical advice. Consult a qualified healthcare provider or pharmacist before combining saffron supplements with medicines or other supplements.